Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Maria Tsikala Vafea"'
Autor:
Markos Kalligeros, Fadi Shehadeh, Evangelia K. Mylona, Matthew Kaczynski, Saisanjana Kalagara, Eleftheria Atalla, Maria Tsikala Vafea, Eleftherios Mylonakis
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 6, Iss 4, p 175 (2021)
Vaccination remains the most effective way to prevent COVID-19. The aim of the present study was to assess the incidence of COVID-19 hospitalizations after vaccination, as well as the effect of prior vaccination on hospitalization outcomes among pati
Externí odkaz:
https://doaj.org/article/365468c7f7b4469ca8fa1969afc91c73
Publikováno v:
International Journal of Infectious Diseases, Vol 106, Iss , Pp 142-154 (2021)
Objectives: Observational and experimental studies suggest that the use of antibiotics close to administration of immune checkpoint inhibitors (ICI) can have a negative effect on tumour response and patient survival, due to microbiome dysbiosis and t
Externí odkaz:
https://doaj.org/article/4b3687dc6cde4e82acf309c9caf94dd8
Publikováno v:
International Journal of Infectious Diseases, Vol 113, Iss , Pp 34-35 (2021)
Externí odkaz:
https://doaj.org/article/274c5fc53f3a4633b639b626c39f802d
Publikováno v:
Case Reports in Infectious Diseases, Vol 2020 (2020)
Mixed invasive mold infections (MIMIs) are considered rare. We present a case of fatal aspergillosis and mucormycosis in an elderly host with history of chronic lymphocytic leukemia (CLL) and potential mold exposures. Notably, he had no classic risk
Externí odkaz:
https://doaj.org/article/95fb6efe03064c699184624ab62649c9
Autor:
Fadi Shehadeh, Gregorio Benitez, Evangelia K Mylona, Quynh-Lam Tran, Maria Tsikala-Vafea, Eleftheria Atalla, Matthew Kaczynski, Eleftherios Mylonakis
Publikováno v:
The Journal of Infectious Diseases. 227:226-235
Background Thymosin-α-1 (Tα1) may be a treatment option for coronavirus disease 2019 (COVID-19), but efficacy and safety data remain limited. Methods Prospective, open-label, randomized trial assessing preliminary efficacy and safety of thymalfasin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13e39c0d560dda63c5932ec3795e6a25
https://doi.org/10.1093/infdis/jiac362
https://doi.org/10.1093/infdis/jiac362
Autor:
Matthew Kaczynski, Gregorio Benitez, Evangelia K Mylona, Quynh-Lam Tran, Eleftheria Atalla, Maria Tsikala-Vafea, Saisanjana Kalagara, Fadi Shehadeh, Eleftherios Mylonakis
Publikováno v:
Open Forum Infectious Diseases. 10
Background Clinical trials for coronavirus disease 2019 (COVID-19) have struggled to achieve diverse patient enrollment, despite underrepresented groups bearing the largest burden of the disease and, presumably, being most in need of the treatments u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38af1ac8afae33ac4d1e2ceb093899b8
https://doi.org/10.1093/ofid/ofad197
https://doi.org/10.1093/ofid/ofad197
Autor:
Maria Tsikala Vafea, Ghady Haidar
Publikováno v:
Infectious Disease Clinics of North America.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86cfbd0dd05329ba3a9b55386040ce33
https://doi.org/10.1016/j.idc.2023.03.002
https://doi.org/10.1016/j.idc.2023.03.002
Autor:
Fadi, Shehadeh, Gregorio, Benitez, Evangelia K, Mylona, Quynh Lam, Tran, Maria, Tsikala-Vafea, Eleftheria, Atalla, Matthew, Kaczynski, Eleftherios, Mylonakis
Publikováno v:
The Journal of infectious diseases.
Thymosin-α-1 (Tα1) may be a treatment option for COVID-19, but efficacy and safety data remain limited.Prospective, open-label, randomized trial assessing preliminary efficacy and safety of thymalfasin (synthetic form of Tα1), compared with standa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9123368dee958825a0735b32e8a25064
https://pubmed.ncbi.nlm.nih.gov/36056913
https://pubmed.ncbi.nlm.nih.gov/36056913
Publikováno v:
Case Reports in Infectious Diseases, Vol 2020 (2020)
Case Reports in Infectious Diseases
Case Reports in Infectious Diseases
Mixed invasive mold infections (MIMIs) are considered rare. We present a case of fatal aspergillosis and mucormycosis in an elderly host with history of chronic lymphocytic leukemia (CLL) and potential mold exposures. Notably, he had no classic risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b35ff450b7c6de01a1d0c8906d670487
https://doi.org/10.1155/2020/8812528
https://doi.org/10.1155/2020/8812528
Autor:
Fadi Shehadeh, Eleftherios Mylonakis, Maria Tsikala Vafea, Joanna Georgakas, Markos Kalligeros, Evangelia K. Mylona, Eleftheria Atalla
Publikováno v:
Cellular and Molecular Bioengineering
Introduction The COVID-19 pandemic has caused an unprecedented health and economic worldwide crisis. Innovative solutions are imperative given limited resources and immediate need for medical supplies, healthcare support and treatments. Aim The purpo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9305690b213e1045d700d7ad3a125b1
http://europepmc.org/articles/PMC7314428
http://europepmc.org/articles/PMC7314428